DWAHF yields 2.83% · JNJ yields 2.13%● Live data
📍 DWAHF pulled ahead of the other in Year 1
Combined, DWAHF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DWAHF + JNJ for your $10,000?
Daiwa House Industry Co., Ltd. engages in the construction business worldwide. It operates through Single-Family Houses; Rental Housing; Condominiums; Existing Homes; Commercial Facilities; Logistics, Business and Corporate Facilities; and Other Businesses segments. The company constructs single-family houses; rents houses; develops, manages, and sells condominiums; purchases, renovates, and resells existing homes; develops commercial facilities; develops and constructs logistics, business, and corporate facilities; and provides real estate agency services. It also manufactures steel and timber housing parts; offers ground survey and reinforcement services; and constructs retail and wholesale, medical and nursing care, office and factory, urban development and industrial park, energy, environmental greening, agriculture, parking and carsharing, and public-private partnership facilities. In addition, the company operates resort hotels and golf courses, business and city hotels, fitness clubs and aesthetic salons, and home centers; provides robotics technologies for use in hospitals, care facilities, factories, and construction sites; manages private homes for the elderly and assisted-living residential facilities for seniors; and offers parking, advertising, travel agency, information technology, and credit card and insurance agency services. Daiwa House Industry Co., Ltd. was incorporated in 1947 and is headquartered in Osaka, Japan.
Full DWAHF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.